High-Dose Methotrexate, Ibrutinib, and Temozolomide in the Treatment of Newly Diagnosed Primary CNS Lymphoma: A Multicenter, Prospective Phase II Study.

Blood Cancer Discov · 2025 · PMC12050966 · PMID 39913173

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Genetic Mutations and Dynamics of ctDNA Patients with a higher IELSG score ( 4 , 5 ) had a higher allele fraction variant (%) and ctDNA concentration in CSF, but the latter did not reach statistical significance (Supplementary Fig.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.